Chardan raised the firm’s price target on EyePoint (EYPT) to $29 from $27 and keeps a Buy rating on the shares. The firm is updating estimates after the company reported Q4 results and provided updates on its Duravyu programs.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EYPT: